These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4327336)

  • 41. [Development of resistance of Mycobacterium tuberculosis to cycloserine, ethionamide, kanamycin, florimycin in experiments in vitro].
    Mkrtchian SV
    Antibiotiki; 1968 Oct; 13(10):907-10. PubMed ID: 4303355
    [No Abstract]   [Full Text] [Related]  

  • 42. Infectivity and pathogenicity of drug-resistant strains of tubercle bacilli studied by aerogenic infection of guinea pigs.
    Cohn ML; Davis CL
    Am Rev Respir Dis; 1970 Jul; 102(1):97-100. PubMed ID: 4316799
    [No Abstract]   [Full Text] [Related]  

  • 43. Resistance system of Mycobacterium bovis B.C.B. to aminoglycoside- and peptide-antibiotics. Comparison of resistant phenotypes between Mycobacterium tuberculosis and Mycobacterium bovis.
    Tsukamura M
    Microbiol Immunol; 1980; 24(1):11-9. PubMed ID: 6153747
    [No Abstract]   [Full Text] [Related]  

  • 44. Some correlations between chemical structure and mode of action of tuberculostatica. Researches on capreomycin and isoxyl.
    Păunescu E; Stoinescu M; Zaharescu C; Drăguşanu E
    Antibiot Chemother; 1970; 16():10-6. PubMed ID: 4108883
    [No Abstract]   [Full Text] [Related]  

  • 45. STUDIES ON CROSS-RESISTANCE BETWEEN CAPREOMYCIN AND CERTAIN OTHER ANTI-MYCOBACTERIAL AGENTS.
    KOSEKI Y; OKAMOTO S
    Jpn J Med Sci Biol; 1963 Feb; 16():31-8. PubMed ID: 14044251
    [No Abstract]   [Full Text] [Related]  

  • 46. Molecular analysis of kanamycin and viomycin resistance in Mycobacterium smegmatis by use of the conjugation system.
    Taniguchi H; Chang B; Abe C; Nikaido Y; Mizuguchi Y; Yoshida SI
    J Bacteriol; 1997 Aug; 179(15):4795-801. PubMed ID: 9244267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Drug activity of bleomycin against tubercle bacilli isolated from pulmonary tuberculous in-patients (author's transl)].
    Endo K
    Jpn J Antibiot; 1973 Dec; 26(6):501-3. PubMed ID: 4131340
    [No Abstract]   [Full Text] [Related]  

  • 48. Pre-XDR & XDR in MDR and Ofloxacin and Kanamycin resistance in non-MDR Mycobacterium tuberculosis isolates.
    Jain A; Dixit P; Prasad R
    Tuberculosis (Edinb); 2012 Sep; 92(5):404-6. PubMed ID: 22789499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Drug sensitivity of the so-called atypical mycobacteria].
    Lucchesi M; Mancini P; Matzeu M
    Ann Ist Carlo Forlanini; 1968; 28(1):25-41. PubMed ID: 4314838
    [No Abstract]   [Full Text] [Related]  

  • 50. [Drug resistance of tubercle bacilli isolated from sputum in previously untreated pulmonary tuberculosis. 3].
    Nakai H; Maekawa N; Nakanishi M; Kawai M; Naito M
    Bull Chest Dis Res Inst Kyoto Univ; 1971 Jan; 4(1):15-24. PubMed ID: 5005481
    [No Abstract]   [Full Text] [Related]  

  • 51. [Studies on resistance of tubercle bacilli to reserve drugs. II. Resistance to viomycin and kanamycin in experimenta tuberculosis in guinea pigs].
    Janowiec M
    Gruzlica; 1966 Oct; 34(10):903-6. PubMed ID: 4292274
    [No Abstract]   [Full Text] [Related]  

  • 52. Sensitivity to ethambutol and to capreomycin in wild strains of Tubercle bacilli isolated from patients previously untreated with these drugs.
    Blitek-Golc D; Zduńczyk-Pawelek H; Antosiewicz A
    Pol Med J; 1971; 10(4):945-51. PubMed ID: 5001656
    [No Abstract]   [Full Text] [Related]  

  • 53. CAPREOMYCIN SUSCEPTIBILITY OF STRAINS RESISTANT TO STREPTOMYCIN AND/OR VIOMYCIN.
    VERBIST L; GYSELEN A
    Am Rev Respir Dis; 1964 Oct; 90():640-1. PubMed ID: 14221679
    [No Abstract]   [Full Text] [Related]  

  • 54. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The genetic basis of cross-resistance between streptomycin, viomycin and kanamycin of tubercle bacilli and atypical mycobacteria.
    Bönicke J; Bönicke R
    Bull Int Union Tuberc; 1970 Jun; 43():229-34. PubMed ID: 4316621
    [No Abstract]   [Full Text] [Related]  

  • 56. [Experimental and clinical study test of capreomycin].
    Kozlova NV; Dzhumaev B; Stepanian ES; Kaminskaia GO
    Antibiotiki; 1976 Jul; 21(7):650-4. PubMed ID: 60080
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemotherapy of chronic pulmonary tuberculosis with polyresistant bacteria with reference to ethambutol and capreomycin.
    Radenbach KL
    Scand J Respir Dis Suppl; 1968; 65():195-206. PubMed ID: 4978461
    [No Abstract]   [Full Text] [Related]  

  • 58. [The study of the in vitro antituberculous activity of capreomycin].
    Ravagnan L; Renzini G
    Antibiotica; 1968 Sep; 6(3):152-61. PubMed ID: 4983488
    [No Abstract]   [Full Text] [Related]  

  • 59. Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis.
    Fattorini L; Iona E; Ricci ML; Thoresen OF; Orrù G; Oggioni MR; Tortoli E; Piersimoni C; Chiaradonna P; Tronci M; Pozzi G; Orefici G
    Microb Drug Resist; 1999; 5(4):265-70. PubMed ID: 10647084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kanamycin susceptibility testing of Mycobacterium tuberculosis using Mycobacterium Growth Indicator Tube and a colorimetric method.
    Bastian I; Rigouts L; Palomino JC; Portaels F
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1934-6. PubMed ID: 11353658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.